Non-compliance: the Achilles' heel of anti-fracture efficacy.
about
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older menVitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosisMind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practiceImplementing adherence to osteoporosis treatments.Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiariesKnowledge on Osteoporosis among NursesKnowledge on osteoporosis of prescriber according to level of medical instituteEfficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.Zoledronic acid infusion for prevention and treatment of osteoporosisBaseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications.Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II.Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.Economic burden of osteoporotic fractures in Austria.Current and emerging therapies for the treatment of osteoporosisEmerging pharmacologic therapies for osteoporosis.Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.DXA scanning in clinical practice.Adherence and persistence with once-daily teriparatide in Japan: a retrospective, prescription database, cohort study.Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis.Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United StatesEmerging drugs for the management of cancer treatment induced bone loss.Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis.Anti-osteoporosis therapy and fracture healing.Safety concerns with the long-term management of osteoporosis.Bisphosphonate use and subsequent hip fracture in South Korea.Compliance, Persistence, and Preferences Regarding Osteoporosis Treatment During Active Therapy or Drug Holiday.Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider.Real-world clinical and economic outcomes for daily teriparatide patients in Japan.Surgical trauma and low-dose methylprednisolone modulate the severity of the acute-phase response induced by zoledronic acid infusion.Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter.Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance.Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.The impact of teriparatide adherence and persistence on fracture outcomes.New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the "3rd Summit on Osteoporosis-CEE", November 2009, Budapest, Hungary.Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database.
P2860
Q24195077-87C88465-77A3-4E2D-83D0-D4475751CBFEQ24241482-B2E28B88-5363-4142-8AD2-0389498B66AAQ30236007-5D154373-AA0E-49D9-94DF-CF4BF318F0C4Q30492459-D279685D-97B6-47E3-B666-0995FCAE84CFQ33610273-4ECD00A4-03C6-432A-91F4-627D17D66BDCQ33617272-EC32070A-6590-4DB9-97D7-CE8E0C5D9798Q33804834-9EC7AD53-1A11-456F-9289-A5CA8A2F62BDQ33822430-2B8F5E4B-F0EF-4975-842B-F74C7D67515FQ33886852-2A4E095D-C751-4E57-AFA6-A5077CFFFE64Q34345697-6B0CD52F-3181-4517-9A8D-13C78A988447Q34440343-6864CED3-7022-46AB-923A-2D1BFFF68283Q34774658-71EA09DF-0020-46DD-8048-88DE117E3363Q35026446-3BB9414D-ED1D-43AF-99BC-CDB8BC55C771Q35641529-C3C1F859-72DD-4923-8739-BD5DAF3201CAQ35707347-D3C97720-1B41-4DFE-85A2-FE7FA5C7ADC2Q36175688-65929039-C45D-4DF9-8890-01F326A4B36BQ36890431-EFB45DB4-B876-442F-9AB5-5721C77EAAA7Q36944034-35487367-52EC-48C0-B2F2-78F48607CD68Q37008062-C265ED68-69A6-4490-80F2-AC96E190D9D8Q37107665-4748B0DA-0BBB-4801-BD4D-139ADBE7E443Q37422363-BD18FD6D-CDE8-4C0D-AC75-C0D1672BCFFEQ37423736-4D77F5FC-2504-4217-8D3E-CBC5ADA9495AQ37639393-755FFDA1-4E5E-46E7-9064-4602072EBFBCQ37670574-DEA2FD1C-DFB2-4705-8DC8-CC86093D1BE3Q37727235-DE3798BB-E267-4381-8372-428102112A8BQ37827874-2692541C-0842-4806-BD7E-B8EFC729959BQ38017621-64C23D00-CD20-4E70-A794-34BFF857E3F0Q38101363-A71B38D1-6F73-4643-9D0C-957E3DEB0263Q38107388-0C557BBE-FD55-4580-9593-1DDD6120EDEEQ38892167-777B1147-2B4C-4B46-A935-CD832F3E0AD2Q38918810-C435D132-610E-44F8-9824-03C8AF050BD7Q39204185-02638633-5CCE-4C31-BE83-7D6979970FE7Q40506119-AE11588A-C802-4748-85D7-01C113F1E2FCQ41115341-1E4959B4-6C52-4BB1-8620-148198DD5936Q41704724-4A256F0A-6EE1-48B5-A7D2-51EB1ADE694DQ42673536-1EF61F87-F8BC-4A6B-8676-83B41DA3032DQ43573067-3A74681E-B26E-48FD-B97D-1082AA5F954CQ43607111-6FD513A0-C628-47DC-B36D-4DDD50951448Q43744780-E7B2CB3C-50F7-4E14-A294-9BA635C260F8Q44538253-7EF2D5F0-C24A-456C-A4DB-C638430ED599
P2860
Non-compliance: the Achilles' heel of anti-fracture efficacy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@ast
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@en
type
label
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@ast
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@en
prefLabel
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@ast
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@en
P2093
P1476
Non-compliance: the Achilles' heel of anti-fracture efficacy.
@en
P2093
B Dawson-Hughes
J A Cramer
J Compston
M L Brandi
P2888
P304
P356
10.1007/S00198-006-0294-8
P407
P577
2007-01-24T00:00:00Z